Literature DB >> 21508367

Inverse correlation between EGFR mutation and FHIT, RASSF1A and RUNX3 methylation in lung adenocarcinoma: relation with smoking status.

Naoki Yanagawa1, Gen Tamura, Hiroyuki Oizumi, Makoto Endoh, Mitsuaki Sadahiro, Teiichi Motoyama.   

Abstract

BACKGROUND: Epidemiological studies have demonstrated a causal link between tobacco smoking and lung cancer. However, lung adenocarcinoma (AC) is also frequently found in non-smokers compared with other non-small cell lung carcinoma (NSCLC) subtypes.
MATERIALS AND METHODS: Mutations of both epithelial growth factor receptor (EGFR) and KRAS, and the methylation status of 10 tumor suppressor or tumor-related genes were examined in 62 ACs, and the relationship with smoking status, and the relationship between the genetic alterations and epigenetic alterations were investigated.
RESULTS: The frequency of EGFR mutation was strongly correlated with smoking status, and the frequency of KRAS mutation, and methylation of retinoic acid receptor beta (RAR-β), p16, FHIT and RASSF1A were weakly related with smoking status. Inverse correlation was found between EGFR mutation and FHIT, RASSF1A and RUNX3 methylation.
CONCLUSION: Tobacco smoking is correlated with the frequencies of EGFR and KRAS mutations as to pathogenesis of ACs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21508367

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  19 in total

1.  RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status.

Authors:  Mohd Feroz Mohd Omar; Kosei Ito; Min En Nga; Ross Soo; Bee Keow Peh; Tuty Muliana Ismail; Bhavin Thakkar; Richie Soong; Yoshiaki Ito; Manuel Salto-Tellez
Journal:  Pathol Oncol Res       Date:  2012-06-24       Impact factor: 3.201

Review 2.  Epigenetics of lung cancer.

Authors:  Scott M Langevin; Robert A Kratzke; Karl T Kelsey
Journal:  Transl Res       Date:  2014-03-12       Impact factor: 7.012

Review 3.  Peripheral Arterial Disease Genetics: Progress to Date and Challenges Ahead.

Authors:  Nathan Belkin; Scott M Damrauer
Journal:  Curr Cardiol Rep       Date:  2017-11-01       Impact factor: 2.931

4.  CDKN2A/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancer.

Authors:  Kit W Tam; Wei Zhang; Junichi Soh; Victor Stastny; Min Chen; Han Sun; Kelsie Thu; Jonathan J Rios; Chenchen Yang; Crystal N Marconett; Suhaida A Selamat; Ite A Laird-Offringa; Ayumu Taguchi; Samir Hanash; David Shames; Xiaotu Ma; Michael Q Zhang; Wan L Lam; Adi Gazdar
Journal:  J Thorac Oncol       Date:  2013-11       Impact factor: 15.609

5.  Common cancer-driver mutations and their association with abnormally methylated genes in lung adenocarcinoma from never-smokers.

Authors:  Mathewos Tessema; Michael R Rossi; Maria A Picchi; Christin M Yingling; Yong Lin; Suresh S Ramalingam; Steven A Belinsky
Journal:  Lung Cancer       Date:  2018-07-11       Impact factor: 5.705

6.  Association between RUNX3 promoter methylation and non-small cell lung cancer: a meta-analysis.

Authors:  Yali Liang; Lianping He; Hui Yuan; Yuelong Jin; Yingshui Yao
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

7.  Cigarette smoking and p16INK4α gene promoter hypermethylation in non-small cell lung carcinoma patients: a meta-analysis.

Authors:  Bo Zhang; Wei Zhu; Ping Yang; Tao Liu; Mei Jiang; Zhi-Ni He; Shi-Xin Zhang; Wei-Qing Chen; Wen Chen
Journal:  PLoS One       Date:  2011-12-13       Impact factor: 3.240

8.  Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis.

Authors:  Lijun Xu; Hongwen Lan; Yushu Su; Jun Li; Jingwen Wan
Journal:  Drug Des Devel Ther       Date:  2015-06-03       Impact factor: 4.162

Review 9.  Cigarette smoke-induced alterations in blood: A review of research on DNA methylation and gene expression.

Authors:  Constanza P Silva; Helen M Kamens
Journal:  Exp Clin Psychopharmacol       Date:  2020-07-13       Impact factor: 3.157

Review 10.  Genomic impact of cigarette smoke, with application to three smoking-related diseases.

Authors:  M Talikka; N Sierro; N V Ivanov; N Chaudhary; M J Peck; J Hoeng; C R E Coggins; M C Peitsch
Journal:  Crit Rev Toxicol       Date:  2012-09-18       Impact factor: 5.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.